Morphological changes in rat striatal boutons after chronic methamphetamine and haloperidol treatment

Area of Science:

• Neuroscience
• Neuropharmacology
• Electron Microscopy

Background:

• Dopaminergic (DA) system alterations are implicated in drug-induced behavioral changes.
• Methamphetamine (MAP) causes behavioral hypersensitivity, suggesting underlying neuroadaptations.
• Electron microscopy allows detailed ultrastructural analysis of synaptic morphology.

Purpose of the Study:

• To investigate the ultrastructural changes in dopaminergic (DA) synaptic boutons in rat striatum following methamphetamine (MAP) treatment.
• To determine if observed morphological changes correlate specifically with MAP-induced behavioral hypersensitivity.
• To examine the effects of haloperidol, alone and in combination with MAP, on DA boutons and behavior.

Main Methods:

• Electron microscopic histochemical analysis of rat striatum.
• Induction of behavioral hypersensitivity using chronic methamphetamine (MAP) administration.
• Assessment of DA boutons with and without mitochondria, and granular synaptic vesicle density.
• Treatment with haloperidol and combined MAP/haloperidol administration.

Main Results:

• Significant reduction in DA boutons lacking mitochondria in MAP-treated rats exhibiting behavioral hypersensitivity.
• No significant change in DA boutons with mitochondria or synaptic vesicle density.
• Similar morphological changes in DA boutons were observed in rats treated with haloperidol alone, without behavioral hypersensitivity.
• Combined administration of haloperidol prevented both the behavioral effects of MAP and the observed changes in DA boutons.

Conclusions:

• Chronic MAP treatment induces specific ultrastructural changes in DA boutons, particularly those without mitochondria.
• These morphological adaptations are not uniquely linked to behavioral hypersensitivity, as similar changes occur with haloperidol treatment.
• The neurochemical environment, modulated by drugs like MAP and haloperidol, influences synaptic plasticity.
• Combined haloperidol administration suggests a protective or counteracting role against MAP-induced neuroadaptations and behavioral changes.